BRIEF published on 02/20/2026 at 07:05, 5 months 21 days ago Le rapport annuel 2025 de BB Biotech met en lumière d'importants résultats financiers. Rapport Annuel BB Biotech Valeur Du Portefeuille Rendements Pour Les Actionnaires Gains Financiers
BRIEF published on 02/20/2026 at 07:05, 5 months 21 days ago BB Biotech's 2025 Annual Report Highlights Strong Financial Gains Annual Report Portfolio Value Shareholder Returns BB Biotech Financial Gains
PRESS RELEASE published on 02/20/2026 at 07:00, 5 months 21 days ago EQS-Adhoc: BB Biotech AG publishes its 2025 annual report BB Biotech AG releases its 2025 annual report, reporting a strong performance with a +34.2% total return in CHF. The annual report includes detailed information on the biotechnology sector and the company's investments Financial Results Investment BB Biotech AG Biotechnology Sector 2025 Annual Report
PRESS RELEASE published on 02/20/2026 at 07:00, 5 months 21 days ago Annual Report 2025: BB Biotech delivers strong performance and portfolio value realization BB Biotech AG's Annual Report 2025 showcases strong performance and portfolio value realization. Shareholder returns, active capital management, and refined investment processes highlighted BB Biotech AG Portfolio Value Shareholder Returns Annual Report 2025 Investment Processes
BRIEF published on 01/23/2026 at 07:05, 6 months 21 days ago BB Biotech AG Reports Significant Profit for 2025 Investment Company BB Biotech AG Drug Developers 2025 Profit Share Price Development
BRIEF published on 01/23/2026 at 07:05, 6 months 21 days ago BB Biotech AG annonce des bénéfices importants pour 2025 BB Biotech AG Société D'investissement Développeurs De Médicaments Bénéfices 2025 Évolution Du Cours De L'action
BRIEF published on 01/23/2026 at 07:05, 6 months 21 days ago BB Biotech Reports Strong Preliminary 2025 Results and Dividend Proposal Dividend Proposal Share Performance BB Biotech Biotech Investment 2025 Financial Results
BRIEF published on 01/23/2026 at 07:05, 6 months 21 days ago BB Biotech annonce des résultats préliminaires solides pour 2025 et une proposition de dividende Proposition De Dividende BB Biotech Performance Des Actions Résultats Financiers 2025 Investissement En Biotechnologie
PRESS RELEASE published on 01/23/2026 at 07:00, 6 months 21 days ago EQS-Adhoc: BB Biotech AG closes the 2025 fiscal year with a profit BB Biotech AG closes the 2025 fiscal year with a profit of approximately CHF 578 million, reflecting share price development. Full report on Feb 20, 2026 BB Biotech AG Profit 2025 Fiscal Year Share Price Development CHF 578 Million
PRESS RELEASE published on 01/23/2026 at 07:00, 6 months 21 days ago BB Biotech: Preliminary full-year 2025 results and dividend proposal BB Biotech AG reports strong full-year 2025 results with +34.2% total return in CHF, +37.0% in EUR, and +53.7% in USD, proposes dividend of CHF 2.25 per share at AGM on March 19, 2026 Dividend Proposal Stock Market Full-year Results BB Biotech AG 2025 Performance
Published on 08/13/2026 at 07:30, 8 minutes ago Battery X Metals Announces Closing of Second Tranche of Private Placement to Advance Corporate Growth Initiatives
Published on 08/12/2026 at 23:30, 8 hours 8 minutes ago CCL Industries Announces Record Results for 2026 Second Quarter
Published on 08/12/2026 at 23:30, 8 hours 8 minutes ago Bolt Metals to Rebrand as 26 Metals Inc. and Adopt the Ticker "IRON," Highlighting Its Focus on Flagship Florália Iron Project in Brazil's Iron Quadrangle
Published on 08/12/2026 at 23:20, 8 hours 18 minutes ago RJK Explorations Ltd. Announces Upsize of Previously Announced Private Placement
Published on 08/13/2026 at 07:03, 34 minutes ago grenke increases Group earnings in the first half of 2026
Published on 08/13/2026 at 07:00, 38 minutes ago Résultat opérationnel et bénéfice semestriel de la Banque Cler en nette hausse
Published on 08/13/2026 at 07:00, 38 minutes ago PolyPeptide delivers +42% growth in H1 2026 and improved EBITDA margin; 2026 full-year guidance updated, now expecting 25-30% revenue growth and high-teens EBITDA margin
Published on 08/11/2026 at 17:45, 1 day 13 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 13 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 13 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 13 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
